• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of the mechanism of PML NB foromation.

Research Project

Project/Area Number 20591117
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionNagoya University

Principal Investigator

FUMIHIKO Hayakawa  Nagoya University, 医学部附属病院, 助教 (30402580)

Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2008: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
KeywordsPAX5 / PML / 融合癌遺伝子 / 白血病 / 発癌機構 / 発ガン機構 / 癌 / アセチル化 / SUMO化 / 分子生物学 / 抗体アレイ
Research Abstract

The purpose of this study is elucidation of the mechanism of PML NB foromation that is important for PML to exert its function. We investigated the mechanism of PML NB disruption by oncoprotein and the mechanism of PML NB restoration by arsenic trioxide (ATO), anti-tumor durg. PAX5-PML is the fist PML-fusion gene discovered other than PML-RARα. We demonstrated that PAX5-PML inhibited PML sumoylation, disrupted PML NB, and conferred apoptosis resistance on cells. Furthermore, treatment with arsenic trioxide induced PML sumoylation and reconstitution of PML NBs, and overcame the anti-apoptotic effect of PAX5-PML in cells. These data shed light to the mechanism of PML NB disruption and indicated that ATO targeted PML portion of PML fusion protein.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (21 results)

All 2011 2010 2009 2008 Other

All Journal Article (10 results) (of which Peer Reviewed: 9 results) Presentation (9 results) Remarks (2 results)

  • [Journal Article] PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML2011

    • Author(s)
      Kurahashi S, Hayakawa F
    • Journal Title

      Oncogene In press

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML.2011

    • Author(s)
      Shingo Kurahashi, et al.
    • Journal Title

      Oncogene

      Volume: in press

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4.2010

    • Author(s)
      Suzuki M, Abe A
    • Journal Title

      Eur J Haematol. 84

      Pages: 229-238

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] 大量化学療法を施行した多発性骨髄腫患者におけるハイリスク群の検討2010

    • Author(s)
      倉橋信悟, 他
    • Journal Title

      臨床血液

      Volume: 51 Pages: 174-180

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] BCR-ABL-independent and RAS/MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4.2010

    • Author(s)
      Momoko Suzuki, et al.
    • Journal Title

      European Journal of Haematology 84

      Pages: 229-238

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] WHO分類第4版における急性骨髄性白血病2009

    • Author(s)
      早川文彦, 他
    • Journal Title

      Trends in Hematological Malignancies 1

      Pages: 40-41

    • Related Report
      2009 Annual Research Report
  • [Journal Article] Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis.2009

    • Author(s)
      Fumihiko Hayakawa
    • Journal Title

      The Journal of Biological Chemistry 283

      Pages: 24420-24425

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy.2008

    • Author(s)
      Abe A, Minami Y
    • Journal Title

      Int J Hematol. 88

      Pages: 471-475

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Acetylation of PML is involved in histone deacetylase Inhibitor-mediated apoptosis.2008

    • Author(s)
      Hayakawa F, Abe A
    • Journal Title

      J Biol Chem. 283

      Pages: 24420-24425

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy.2008

    • Author(s)
      Akihiro Abe
    • Journal Title

      Internal Journal of Hematology 88

      Pages: 471-475

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Presentation] A novel direct STAT3 inhibitor OPB-31121 induces tumor-specific growth inhibition in a wide range of hematopoietic malignancies and effectively suppresses the chemotherapy resistant quiescent cells in vivo. The American Society of Hematology2010

    • Author(s)
      Hayakawa F, Sugimoto K
    • Organizer
      52nd Annual Meeting
    • Place of Presentation
      Orlando, FL, USA
    • Year and Date
      2010-12-06
    • Related Report
      2010 Final Research Report
  • [Presentation] PAX5 phosphorylation by MAP kinase signal potentially suppresses PAX5 function and might be a trigger of the plasma cell differentiation.2010

    • Author(s)
      Yasuda T, Hayakawa F
    • Organizer
      The American Society of Hematology, 52nd Annual Meeting.
    • Place of Presentation
      Orlando, FL, USA
    • Year and Date
      2010-12-06
    • Related Report
      2010 Final Research Report
  • [Presentation] PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML2010

    • Author(s)
      Shingo Kurahashi, et al.
    • Organizer
      52^<nd> annual meeting of American Society of Hematology
    • Place of Presentation
      Orlando
    • Year and Date
      2010-12-06
    • Related Report
      2010 Annual Research Report
  • [Presentation] PAX5-PML acts as a dual dominant- negative form of PAX5 and PML. The American Society of Hematology2010

    • Author(s)
      Kurahashi S, Hayakawa F
    • Organizer
      52nd Annual Meeting
    • Place of Presentation
      Orlando, FL, USA
    • Year and Date
      2010-12-04
    • Related Report
      2010 Final Research Report
  • [Presentation] 急性リンパ性白血病に認められたPAX5-PML融合蛋白の機能解析:PAX5-PMLはPAX5およびPMLの機能を抑制する2010

    • Author(s)
      倉橋信悟, 他
    • Organizer
      第72回日本血液学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2010-09-25
    • Related Report
      2010 Annual Research Report
  • [Presentation] PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML2009

    • Author(s)
      Shingo Kurahashi, et al.
    • Organizer
      51^<st> annual meeting of American Society of Hematology
    • Place of Presentation
      ニューオーリンズ
    • Year and Date
      2009-12-07
    • Related Report
      2009 Annual Research Report
  • [Presentation] 急性リンパ性白血病に認められたPAX5-PML融合蛋白の機能解析 : PAX5-PMLはPAX5およびPMLの機能を抑制する2009

    • Author(s)
      倉橋信悟, 他
    • Organizer
      第71回に本血液学会学術集会
    • Place of Presentation
      京都
    • Year and Date
      2009-10-24
    • Related Report
      2009 Annual Research Report
  • [Presentation] PAX5-PML acts as a dual dominant- negative form of PAX5 and PML.2009

    • Author(s)
      Hayakawa F, Kurahashi S
    • Organizer
      5th International Symposium on ACUTE PROMYELOCYTIC LEUKEMIA
    • Place of Presentation
      Rome, Italy
    • Year and Date
      2009-09-25
    • Related Report
      2010 Final Research Report
  • [Presentation] PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML2009

    • Author(s)
      Fumihiko Hayakawa, et al
    • Organizer
      5th International Symposium on Acute Promyelocytic Leukemia
    • Place of Presentation
      ローマ
    • Year and Date
      2009-09-25
    • Related Report
      2009 Annual Research Report
  • [Remarks] ホームページ等

    • Related Report
      2010 Final Research Report
  • [Remarks]

    • URL

      http://www.med.nagoya-u.ac.jp/medical/1639/1674/ketsuekishuyounaikagaku.html

    • Related Report
      2010 Annual Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi